2.5. Exclusion Criteria
hepatitis B, ascites, anorexic, alcoholism, allergy, eating disorders, drug abuse, HIV; major cognitive or psychiatric disorders, liver deficiency
HEPATITIS B, ASCITES, ANOREXIC, DISEASE, ALLERGY, HYPERSENSITIVITY
Any of the following was regarded as a criterion for exclusion from enrolment into the study: subjects currently enrolled in another clinical study; subjects having finished another clinical study within 4 weeks before inclusion; hypersensitivity, allergy or intolerance to any compound of the test products (e.g., acacia gum); previous implantation of a cardiac pacemaker or other active implants; sulfonylurea treatment; any disease or condition that might have significantly compromised the hepatic (ascites), hematopoietic, renal, endocrine, pulmonary, central nervous, cardiovascular, immunological, dermatological or gastrointestinal system, or any other body system, with the exception of the conditions defined by the inclusion criteria; history of or present liver deficiency as defined by Quick test result < 70%; regular medical treatment, including OTC, that may have impacted the study aims (e.g., probiotics containing supplements, laxatives, steroids, etc.); history of hepatitis B or C, or HIV; major cognitive or psychiatric disorders; subjects who were scheduled to undergo any diagnostic intervention or hospitalization that may have caused protocol deviations; simultaneous study participation of members of the same household; pregnancy and lactation; ascites as assessed with sonography; any diet to lose body weight; eating disorders or vegan diet; anorexic drugs; present drug abuse or alcoholism; legal incapacity.